FIELD: medicine, pharmaceutics.
SUBSTANCE: declared formulation of the combined pharmaceutical chondroprotective drug presented in a solid dosage form contains as active substances sodium chondroitin sulphate and glucosamine sulphate sodium chloride, a binding agent, antifriction substances, an aerating agent, an excipient; the composition is film-coated. The ingredients are taken in proportions, wt %: sodium chondroitin sulphate - 10-35, glucosamine sulphate sodium chloride - 15-45, the binding agent (low-molecular povidone and potato starch) - 3.1-11, the antifriction substances (aerosil, calcium stearate and talc) - 2.7-5, the aerating agent (kollidon) - 1.7-10, the excipient (ludipress) - 10-44.2. The coating ingredients are taken in proportions, wt %: film-forming material (hypromellose) - 1-2, a plasticiser (macrogol and propylene glycol) - 1-1.8, a pigment (titanium dioxide) - 0.5-1.
EFFECT: auxiliary ingredients enables high release rate of a tabletted mass, complete drug absorption and shelf-life stability of all measures.
3 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2381029C1 |
GLUCOSAMINE PROLONGED RELEASE DOSAGE FORM | 2011 |
|
RU2521231C2 |
MEDICINAL COMPOSITION FOR TREATING JOINT DISEASES (VERSIONS) | 2009 |
|
RU2408380C1 |
MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
PHARMACEUTICAL COMPOSITION ELICITING ANTIVIRAL ACTIVITY AS SOLID DOSED FORMULATION AND METHOD FOR ITS PREPARING | 2003 |
|
RU2254860C2 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
IMMEDIATE-RELEASE SOLID DOSAGE FORM OF HYDROXYCHLOROQUINE AND METHOD FOR PRODUCING IT | 2014 |
|
RU2580656C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
PHARMACEUTICAL ANTIGLAUCOMA COMPOSITION | 2009 |
|
RU2402316C2 |
COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VERSIONS) | 2011 |
|
RU2471482C1 |
Authors
Dates
2011-10-27—Published
2010-04-06—Filed